Comments on: BNT-325 by BioNTech for Castration-Resistant Prostate Cancer (CRPC): Likelihood of Approval /data-insights/bnt-325-biontech-castration-resistant-prostate-cancer-crpc-likelihood-of-approval/ The leading site for news and procurement in the pharmaceutical industry Sun, 05 Jan 2025 17:10:18 +0000 hourly 1 https://wordpress.org/?v=6.7.2